Phospholipid metabolites in recurrent glioblastoma: in vivo markers detect different tumor phenotypes before and under antiangiogenic therapy.

by Elke Hattingen, Oliver Bähr, Johannes Rieger, Stella Blasel, Joachim Steinbach, Ulrich Pilatus
Published 2013-01-01

Bevacizumab for Patients with Recurrent Gliomas Presenting with a Gliomatosis Cerebri Growth Pattern

by Michael C. Burger, Iris C. Mildenberger, Marlies Wagner, Michel Mittelbronn, Joachim P. Steinbach, Oliver Bähr
Published 2017-03-01

Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy Study.

by Eike Steidl, Ulrich Pilatus, Elke Hattingen, Joachim P Steinbach, Friedhelm Zanella, Michael W Ronellenfitsch, Oliver Bähr
Published 2016-01-01

Ventriculoperitoneal Shunts Equipped with On-Off Valves for Intraventricular Therapies in Patients with Communicating Hydrocephalus due to Leptomeningeal Metastases

by Michael C. Burger, Marlies Wagner, Kea Franz, Patrick N. Harter, Oliver Bähr, Joachim P. Steinbach, Christian Senft
Published 2018-08-01

Bevacizumab for Patients with Recurrent Multifocal Glioblastomas

by Michael C. Burger, Stella Breuer, Hans C. Cieplik, Patrick N. Harter, Kea Franz, Oliver Bähr, Joachim P. Steinbach
Published 2017-11-01

Matching Quantitative MRI Parameters with Histological Features of Treatment-Naïve <i>IDH</i> Wild-Type Glioma

by Gabriele D. Maurer, Julia Tichy, Patrick N. Harter, Ulrike Nöth, Lutz Weise, Johanna Quick-Weller, Ralf Deichmann, Joachim P. Steinbach, Oliver Bähr, Elke Hattingen
Published 2021-08-01

Non-Invasive Measurement of Drug and 2-HG Signals Using ¹⁹F and ¹H MR Spectroscopy in Brain Tumors Treated with the Mutant IDH1 Inhibitor BAY1436032

by Katharina J. Wenger, Christian Richter, Michael C. Burger, Hans Urban, Stefan Kaulfuss, Patrick N. Harter, Sridhar Sreeramulu, Harald Schwalbe, Joachim P. Steinbach, Elke Hattingen, Oliver Bähr, Ulrich Pilatus
Published 2020-10-01

Hypoxia enhances the antiglioma cytotoxicity of B10, a glycosylated derivative of betulinic acid.

by Sebastian Fischer, Michael W Ronellenfitsch, Anna-Luisa Thiepold, Patrick N Harter, Sebastian Reichert, Donat Kögel, Reinhard Paschke, Michel Mittelbronn, Michael Weller, Joachim P Steinbach, Simone Fulda, Oliver Bähr
Published 2014-01-01

Regorafenib CSF Penetration, Efficacy, and MRI Patterns in Recurrent Malignant Glioma Patients

by Pia S. Zeiner, Martina Kinzig, Iris Divé, Gabriele D. Maurer, Katharina Filipski, Patrick N. Harter, Christian Senft, Oliver Bähr, Elke Hattingen, Joachim P. Steinbach, Fritz Sörgel, Martin Voss, Eike Steidl, Michael W. Ronellenfitsch
Published 2019-11-01